Your Health Questions
Answered by Professionals

Endoscopic non-healing means your gut lining still shows ulcers or inflammation on endoscopy despite treatment. This matters because unhealed mucosa raises the risk of disease flares, hospitalizations, complications like strictures or fistulas, and, in some conditions, colorectal cancer. Common causes include inadequate medication response, low drug levels (or anti-drug antibodies neutralizing biologics), ongoing triggers such as NSAIDs, smoking, or stress, structural damage, missed infections like C. difficile or CMV, or an overlapping condition such as celiac disease. Evidence-based next steps include therapeutic drug monitoring, switching to a different drug mechanism, combination therapy, short-term steroids, targeted nutrition, and surgical consultation when appropriate. Adherence checks and trigger review are also essential. Because endoscopic non-healing has many possible drivers—and the right fix depends on which one applies to you—the fastest way to clarify your situation is to map your symptoms against likely causes before your next appointment. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's driving your unhealed inflammation and get personalized guidance on next steps to discuss with your doctor. Reviewed for medical accuracy: 07/03/2026

Tenesmus—the persistent urge to pass stool despite an empty rectum—is most commonly caused by rectal inflammation (IBD, proctitis, infections), IBS hypersensitivity, constipation, or pelvic floor dysfunction, and rarely by tumors. Red-flag symptoms requiring urgent care include rectal bleeding, black stools, unintentional weight loss, fever, severe pain, or symptoms lasting more than 2–3 weeks. Treatment is cause-specific and may include calming inflammation, optimizing stool consistency, managing IBS through diet and stress strategies, pelvic floor therapy, medication review, treating infections, and daily comfort measures. In some cases, tests like colonoscopy may be needed. Because tenesmus has many possible causes—some benign, some serious—identifying the underlying trigger is essential to finding relief and knowing when to seek care. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you evaluate your specific symptoms, flag urgent warning signs, and guide your next steps with clarity and confidence. Reviewed for medical accuracy: 07/10/2026

Emotional numbness and low motivation often point to **anhedonia**, a treatable disruption in the brain's dopamine-driven reward system. This is why standard serotonin-based antidepressants (SSRIs) sometimes fail to relieve these specific symptoms. **Evidence-based treatment options for anhedonia include:** - **Medication adjustments:** Dopamine-targeting drugs like bupropion, or newer rapid-acting options such as esketamine or ketamine - **Targeted therapies:** Behavioral activation and cognitive behavioral therapy (CBT) - **Brain stimulation:** Transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT) - **Lifestyle support:** Improved sleep, regular exercise, balanced nutrition, and small social interactions Seek urgent help immediately if you experience self-harm thoughts. Because anhedonia can stem from many overlapping causes—and the right treatment depends on your unique symptom pattern—understanding what you're actually experiencing is the critical first step. A free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms in minutes, identify possible conditions, and prepare you with clear next steps to discuss with a clinician—so you don't waste months on treatments that miss the mark. Reviewed for medical accuracy: 06/23/2026

Ongoing IBD flares often stem from four key causes: a mismatch between your medication and biology, smoldering inflammation your symptoms don't reveal, drug levels that are too low, or non-inflammatory look-alikes like IBS or infection. Objective tests—such as fecal calprotectin and therapeutic drug monitoring—help pinpoint the true cause and guide next steps. New remote monitoring IBD trials now use app-based symptom tracking, at-home stool tests, medication level optimization, and virtual specialist access to detect inflammation early, adjust therapy faster, reduce hospitalizations, and support switching drug classes when needed. Seek urgent care for severe pain, high fever, heavy bleeding, or rapid weight loss. Because flare causes vary so widely—and treatment depends on identifying the *right* one—guessing can delay relief and worsen outcomes. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's driving your symptoms and confidently plan your next steps. Reviewed for medical accuracy: 07/09/2026

Still flaring on Skyrizi? Several factors could explain persistent symptoms despite treatment. Common causes include primary non-response (the medication never worked for you), secondary loss of response due to low drug levels or anti-drug antibodies, mechanical complications like strictures or abscesses, or an alternative diagnosis being missed. Next steps typically involve targeted blood and stool testing, Skyrizi dose optimization or a short steroid course, switching to another biologic or a JAK inhibitor, and treating any complications directly. Urgent red flags—such as severe pain, high fever, or obstruction symptoms—warrant immediate care. Because flare causes vary widely and treatment paths differ significantly, understanding your specific symptom pattern is the fastest way to clarify next steps with your care team. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to get personalized insight into what may be driving your flare and how to move forward confidently. Reviewed for medical accuracy: 07/03/2026

Inflammatory bowel disease (IBD) research now supports a proactive, personalized path to remission that goes beyond symptom relief. Today's care targets deep healing through treat-to-target monitoring, advanced biologics, small-molecule drugs, and emerging precision medicine and microbiome therapies. If you're still flaring, several factors may be at play: hidden inflammation, drug antibodies, diet, lifestyle, or eligibility for clinical trials. Recognizing warning signs early—and knowing when to reassess with your GI—can meaningfully change your care plan and outcomes. Because IBD symptoms overlap with many other conditions, and because flares can signal treatment failure or complications, understanding what your body is telling you is critical. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's going on, prepare smarter questions for your GI, and identify the right next steps—before your next flare dictates them for you. Reviewed for medical accuracy: 07/09/2026

If your ulcerative colitis keeps flaring, several factors matter. New research shows anti-inflammatory eating plans like the Mediterranean diet can ease symptoms and may support remission, but they do not replace proven medications such as 5-ASA, biologics, or JAK inhibitors. Key next steps include: - **Confirm active inflammation** with stool and blood markers or endoscopy - **Check medication adherence** and rule out infections like C. difficile - **Optimize or escalate therapy** with your gastroenterologist - **Use supervised diet adjustments** for symptom relief - **Seek urgent care** for red flags like heavy bleeding, high fever, or severe pain Because flare causes vary widely—from infection to under-dosed medication to dietary triggers—understanding your specific symptom pattern is critical before your next appointment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify likely contributors, flag urgent warning signs, and prepare focused questions for your doctor—so you can act on the right next step, faster. Reviewed for medical accuracy: 07/02/2026

New IBD treatments in 2026 offer expanded options for people still experiencing flares. These include next-generation IL-23 inhibitors, selective JAK inhibitors, and S1P modulators, alongside more personalized, data-driven care targeting deeper remission and mucosal healing. Key considerations include safety tradeoffs, monitoring requirements, and recognizing when it's time to switch therapies. Below, you'll find who benefits most from each option, key differences between drugs, combination strategies, lifestyle and surgery considerations, and step-by-step next actions to discuss with your gastroenterologist. If you're experiencing ongoing IBD symptoms like abdominal pain, diarrhea, blood in stool, or fatigue, understanding what's driving your flare is the first step toward the right treatment. Taking a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify possible causes, and prepare targeted questions for your gastroenterologist—so you can make the most of your next visit and get closer to lasting remission. Reviewed for medical accuracy: 07/09/2026

Skyrizi vs. Stelara for Crohn's disease: Head-to-head data show Skyrizi (risankizumab) generally achieves higher endoscopic remission rates than Stelara (ustekinumab), with similar or slightly higher clinical remission and comparable safety profiles—particularly in patients who have failed anti-TNF therapy. Key factors to weigh include exact remission rates, durability of response, ideal patient profiles for each biologic, dosing logistics, safety nuances, and red flags that should guide your next conversation with a gastroenterologist. Because Crohn's symptoms often overlap with other GI conditions—and treatment decisions hinge on accurately identifying what's driving your symptoms—it's worth clarifying your picture before your next appointment. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on, surface possible causes, and get personalized guidance on next steps. It takes just a few minutes and can help you walk into your gastroenterologist visit better prepared to discuss whether Skyrizi, Stelara, or another option fits your situation. Reviewed for medical accuracy: 07/10/2026

Struggling with ulcerative colitis flares despite treatment? Today's UC treatment options have grown significantly. Newer therapies include gut-selective biologics like vedolizumab, IL-12/23 inhibitors such as ustekinumab, oral JAK inhibitors (tofacitinib, upadacitinib), and the S1P modulator ozanimod—each offering hope after prior therapy failure when combined with proper safety screening and mucosal healing monitoring. Your best next step depends on disease severity, extent, prior treatment response, comorbidities, and pregnancy plans. Options may include switching medication mechanisms, enrolling in a clinical trial, intensifying monitoring, or considering surgery. Watch for urgent red flags detailed below. Because UC symptoms overlap with other conditions—and choosing the right next step depends on understanding your specific pattern of symptoms—taking a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's happening in your body, identify red flags early, and prepare more productive conversations with your gastroenterologist about which advanced therapy may fit you best. Reviewed for medical accuracy: 07/10/2026

Still flaring with IBD despite treatment? AI-guided drug discovery is rapidly identifying new inflammatory targets, predicting which patients respond to specific biologics, and accelerating safer, more precise therapies into clinical trials and everyday care. Persistent flares may signal the need to reassess your diagnosis, recheck inflammation markers (CRP, fecal calprotectin), optimize drug levels, or explore clinical trials testing next-generation therapies. Knowing the urgent warning signs—severe pain, bleeding, fever, or rapid weight loss—and realistic treatment timelines can shape your next medical steps. Because IBD symptoms overlap with many other conditions, the smartest next move is to clarify what's actually driving your flare before your next appointment. A free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you pinpoint likely causes, flag red flags, and prepare targeted questions for your gastroenterologist—so you walk in informed and leave with a clearer plan. Reviewed for medical accuracy: 06/22/2026

Clinical trial patient stipends for inflammatory bowel disease (IBD) help offset out-of-pocket costs like travel, parking, childcare, and lost wages from time off work. These stipends make it easier to participate in studies that may provide access to innovative treatments and closer monitoring than routine care typically offers. Before enrolling, consider key factors: eligibility requirements, possible side effects, the chance of receiving a placebo, visit frequency and time commitment, tax implications of stipend payments, and how the trial team will coordinate with your current gastroenterologist. Knowing when to seek urgent care during a trial is equally important. If you're weighing a clinical trial because your IBD symptoms feel unpredictable or poorly controlled, the smartest first step is understanding what your body is telling you. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify possible causes, and guide your next conversation with a doctor or trial coordinator — so you can make an informed decision about whether a study is right for you. Reviewed for medical accuracy: 06/26/2026

Still flaring with IBD despite treatment? Medically supervised clinical trials are a legitimate next step — not a last resort. They offer access to new targeted therapies, close specialist monitoring, and often no-cost study care for eligible patients. Whether a trial fits depends on your disease severity, prior response or intolerance to medications, eligibility criteria, safety details (including placebo use and rescue plans), and knowing when symptoms require urgent care. Review the full guidance below and discuss the right next steps with your doctor. Not sure if your current symptoms point toward trial eligibility, a treatment change, or something more urgent? A free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's driving your flare, flag red-flag symptoms, and prepare a clear summary to bring to your GI specialist — so you walk into your next appointment ready to make informed decisions. Reviewed for medical accuracy: 07/09/2026

Still flaring with mild to moderate ulcerative colitis (UC)? New clinical research studies may be a vital next step. These trials offer access to targeted therapies and close monitoring aimed at symptom remission, endoscopic healing, reduced steroid use, and prevention of long-term complications. Key factors to consider include: who qualifies for UC trials, safety oversight and placebo protocols, and practical steps to discuss with your gastroenterologist before enrolling. Before your next appointment, it's worth clarifying exactly what's driving your flare. Symptoms like urgency, bleeding, fatigue, and abdominal pain can overlap with other GI conditions, and understanding your specific pattern helps you ask better questions and make informed decisions about trials or therapy changes. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> now to better understand what's going on and confidently navigate your next steps. Reviewed for medical accuracy: 07/09/2026

Nutritional therapy trials for Crohn's disease may be a smart next step if you're still flaring despite medication. Evidence-based, supervised diets—such as exclusive or partial enteral nutrition (EEN/PEN), the Crohn's Disease Exclusion Diet (CDED), and other anti-inflammatory approaches—can complement your current treatment by reducing inflammation, supporting gut healing, improving quality of life, and sometimes lowering steroid dependence. Below, you'll find key details to shape your next steps: who benefits most, what the research shows, safety and monitoring guidance, how to find trials, questions to ask your doctor, and red flag symptoms that need urgent care. Because Crohn's symptoms overlap with many other GI conditions, it's important to clarify what's driving your flare before pursuing a trial. Taking a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you organize your symptoms, identify possible causes, and walk into your next appointment prepared to discuss whether nutritional therapy is right for you. Reviewed for medical accuracy: 07/09/2026

Still flaring despite ulcerative colitis treatment? New oral clinical trials may be your next step. These studies offer access to investigational targeted pills — including JAK inhibitors, S1P modulators, and TYK2 inhibitors — with close specialist monitoring. Benefits, risks, and eligibility vary, so review options with your gastroenterologist. Key factors to weigh include: how to confirm active inflammation, what the trial process and costs involve, potential side effects and safety safeguards, and urgent red-flag symptoms that require immediate care. Because ongoing UC flares can signal worsening inflammation — or point to another condition entirely — it's important to understand your symptoms clearly before pursuing a trial or changing treatment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you identify possible causes, gauge urgency, and prepare focused questions for your gastroenterologist, so your next step is the right one. Reviewed for medical accuracy: 07/09/2026

Paid IBD clinical trials near you may be a smart next step if you're still flaring despite standard treatment. These studies offer access to emerging therapies, closer medical monitoring, and financial compensation for your time. Key factors to weigh include eligibility requirements, safety oversight, potential side effects, placebo assignment, visit frequency, coordinating with your GI, and locating active studies in your area. Before pursuing a trial, it's important to understand what's driving your symptoms and whether your current flare warrants new treatment options. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your situation in minutes, identify possible causes, and guide your next conversation with your GI—so you can make an informed decision about trials, therapies, or other next steps. Reviewed for medical accuracy: 07/09/2026

Small molecule IBD drugs are oral, targeted therapies that work inside immune cells to control Crohn's disease and ulcerative colitis. They can help people who continue to flare despite steroids, immunomodulators, or biologics. **Key types include:** - **JAK inhibitors:** tofacitinib, upadacitinib - **S1P modulators:** ozanimod **Benefits:** Fast-acting, taken by mouth, and no risk of anti-drug antibodies. **Considerations:** Candidacy depends on age, health history, and prior treatments. Monitoring is required for infections, shingles, cholesterol changes, and rare blood clots. If you're experiencing ongoing IBD symptoms or flares, understanding your situation is the first step toward finding the right treatment. Because small molecule drugs come with specific benefits and risks, knowing where you stand symptom-wise can help you have a more productive conversation with your doctor. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on and navigate your next steps with confidence. Reviewed for medical accuracy: 07/09/2026

If your child's IBD keeps flaring despite treatment, several factors may be at play: medication mismatch, hidden inflammation, growth changes, or more aggressive disease progression. Pediatric IBD clinical trials can also provide access to new targeted therapies under close safety monitoring. Knowing when to consider a trial, which tests and treatment optimizations to ask your doctor about, and which urgent symptoms require immediate care can significantly shape your child's next steps. Because ongoing flares can signal deeper issues that need faster action, taking a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify what's happening, identify red-flag symptoms, and prepare targeted questions for your pediatric gastroenterologist—so you can move forward with clarity and confidence. Reviewed for medical accuracy: 07/09/2026

Ulcerative colitis flares that won't heal often signal that your colon is still inflamed beneath the surface. Common reasons include therapy that isn't strong enough, incomplete mucosal healing despite fewer symptoms, ongoing steroid dependence, or delayed treatment escalation — all of which increase long-term risks like hospitalization and surgery. Several factors matter when planning next steps. If you are biologic-naive, you may qualify for closely monitored clinical trials offering access to new biologics, oral small molecules, and precision strategies that could reshape your treatment path. Confirming active inflammation, assessing eligibility, and recognizing when urgent care is needed are all critical. Because ulcerative colitis symptoms overlap with many other conditions — and because untreated inflammation can quietly progress — the fastest way to clarify what's driving your flare is to evaluate your symptoms now. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on and navigate your next steps with confidence. Reviewed for medical accuracy: 06/26/2026

New ulcerative colitis data shows Rinvoq (a JAK inhibitor pill) often delivers faster induction and higher early remission rates, especially in biologic-experienced patients, while Omvoh (an IL-23p19 infusion/injection) demonstrates strong 1-year maintenance among responders with a more targeted safety profile. The better UC treatment depends on how quickly you need relief, pill versus infusion preference, prior biologic history, and cardiovascular risk given JAK inhibitor boxed warnings. Key trial numbers, safety nuances, and mechanism-switch guidance below can help shape your next conversation with your gastroenterologist. Because UC symptoms and treatment response vary widely person to person, the smartest first step is understanding your own symptom pattern before comparing therapies. A free, instant, AI-powered <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify flare severity, flag red-flag symptoms, and walk into your GI appointment with clearer questions—making the Rinvoq vs. Omvoh decision far more personalized. Reviewed for medical accuracy: 07/10/2026

Why is your IBD still flaring despite treatment? Ongoing inflammation can stem from immune pathway shifts, anti-drug antibodies, gut barrier damage, or microbiome imbalance. Emerging therapies now offer new hope, including selective IL-23 inhibitors, S1P receptor modulators, next-generation JAK inhibitors, anti-TL1A biologics, and microbiome-based treatments. Key next steps include therapeutic drug monitoring, objective disease testing (labs, imaging, endoscopy), evaluating clinical trial eligibility after prior treatment failures, and recognizing red-flag symptoms that require urgent care. Because persistent IBD symptoms can signal treatable causes, like sub-therapeutic drug levels or a shifting inflammatory pathway, identifying what's driving your flare is critical before your next appointment. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, spot urgent warning signs, and walk into your GI visit prepared to advocate for the right tests and treatment adjustments. Reviewed for medical accuracy: 07/09/2026

Persistent IBD flares are often caused by incomplete or lost medication response, microscopic inflammation, suboptimal dosing, or overlapping conditions. Clinical trials may offer access to cutting-edge therapies, close specialist monitoring, and the potential for better disease control. Key factors to consider include: the exact tests needed to confirm inflammation, how to optimize current therapy, addressing nutrition, stress, and sleep, urgent red flags requiring immediate action, and the right questions to ask your doctor about emerging treatments and whether an IBD clinical trial is right for you. Because persistent IBD flares can stem from many overlapping causes—some subtle, some urgent—identifying your specific pattern of symptoms is the critical first step before adjusting treatment or exploring trials. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you pinpoint what may be driving your flares, flag red flags that need urgent care, and give you a clearer roadmap for your next conversation with your gastroenterologist. Reviewed for medical accuracy: 07/09/2026

Anti-TNF resistance happens when ulcerative colitis or Crohn's disease flares despite biologic treatment. Common causes include anti-drug antibodies, low drug levels, shifts in inflammatory pathways, or structural bowel damage. Confirming the cause requires objective testing and therapeutic drug monitoring. Next steps may include dose optimization, adding an immunomodulator, switching to another anti-TNF, or transitioning to a different drug class such as vedolizumab, ustekinumab, IL-23 inhibitors, or JAK inhibitors. Recognizing red-flag symptoms that require urgent care is equally important. Because anti-TNF resistance can mimic other conditions and delay relief, identifying the right next step quickly matters. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what your symptoms may mean and how to navigate your conversation with your gastroenterologist. Reviewed for medical accuracy: 06/23/2026

If your ulcerative colitis (UC) is still flaring despite treatment, several factors may be responsible: poor medication fit, secondary loss of response, persistent inflammation, or non-UC causes such as infection or IBS overlap. Next steps typically involve objective reassessment—optimizing current therapy or switching drug classes. Options may include oral JAK inhibitors for UC like tofacitinib or upadacitinib, which require appropriate screening and monitoring. Key safety considerations, red flag symptoms, guidance on tests, drug levels, clinical trials, and when surgery is appropriate are detailed below, all of which can significantly influence the best path forward with your care team. Because ongoing UC flares can signal anything from a simple treatment adjustment to a more serious underlying issue, it's important to clarify what your symptoms may mean before your next appointment. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what's going on and confidently navigate your next steps. Reviewed for medical accuracy: 07/09/2026

Persistent IBD flares despite medication usually occur when treatment targets the wrong immune pathway, drug levels are too low, anti-drug antibodies block absorption, fixed scarring is present, or symptoms stem from non-inflammatory causes like IBS, bile acid diarrhea, SIBO, or infection. Effective next steps often involve precision medicine strategies: therapeutic drug and antibody monitoring, treat-to-target biomarker tracking (CRP, fecal calprotectin), earlier switching to better-matched biologics or small molecules, nutrition support, and knowing when to seek urgent care. Details and doctor questions are outlined below. Because ongoing flares can have very different root causes—each requiring a different fix—identifying yours early matters. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you pinpoint likely drivers of your symptoms and clarify the right next steps to discuss with your GI provider. Reviewed for medical accuracy: 07/09/2026

Ulcerative colitis flares that continue despite microbiome therapy usually mean one of four things: active inflammation is still driving the disease, your probiotic strains or doses aren't effective, diet and stress are undermining progress, or you need combination therapy with standard UC medications rather than microbiome approaches alone. Evidence-based next steps include therapeutic drug monitoring, switching biologic classes, considering JAK or S1P inhibitors, and evaluating fecal microbiota transplant (FMT) or clinical trials. It's also critical to watch for red-flag symptoms that require urgent care. Several factors and lab tests can change your treatment plan — see the complete details below. Because persistent UC flares can signal anything from medication failure to complications needing urgent evaluation, understanding your specific symptom pattern is the fastest way to know what to do next. Take a free, instant, private <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to clarify what's driving your flare and get guidance on the right next steps — before your condition worsens. Reviewed for medical accuracy: 07/09/2026

IBD clinical trials without a placebo group guarantee every participant receives active treatment, making them a more ethical and practical option for people still flaring after standard therapies. These trials offer access to emerging drugs, closer monitoring, and often compare new therapies to already-approved medications or different dosages. Key considerations include: - All treatments are investigational - Side effects and eligibility criteria vary - Study designs differ (new drug vs. approved drug, or dose comparisons) - Discussion with your gastroenterologist is essential Because IBD symptoms like abdominal pain, diarrhea, rectal bleeding, and fatigue can overlap with other conditions, understanding what's driving your flare is the critical first step before exploring trial options. A quick, free <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you clarify your symptoms, identify possible causes, and prepare more informed questions for your gastroenterologist about whether a no-placebo IBD trial may be right for you. Reviewed for medical accuracy: 07/09/2026

When Crohn's disease keeps flaring, choosing between anti-TNFs and anti-integrins depends on several key factors. Anti-TNFs typically work faster and are preferred for treating fistulas, while anti-integrins are more gut-selective, carry a lower infection risk, and offer similar long-term durability for many patients. Below, you'll find the complete answer on why Crohn's treatments stop working, how to decide between optimizing your current dose or switching therapies under a treat-to-target approach, who benefits most from each biologic option, and the urgent symptoms that should guide your next steps. If your Crohn's symptoms are worsening or you're unsure whether your current treatment is still working, don't wait to find clarity. Take a free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> to better understand what your body is telling you, identify red-flag signs that warrant urgent care, and get personalized guidance on how to navigate your next conversation with your gastroenterologist. It only takes a few minutes and could help you act sooner rather than later. Reviewed for medical accuracy: 06/23/2026

**Why Combination Therapy May Work When Single-Drug IBD Treatment Fails** Persistent IBD flares on one medication are common and often signal multi-pathway inflammation, loss of response from anti-drug antibodies, low drug levels, or high-risk disease that outpaces monotherapy. Landmark clinical trials (SONIC and UC SUCCESS) show that **combination therapy for IBD**—typically a biologic paired with an immunomodulator—improves steroid-free remission and mucosal healing compared to monotherapy. However, added infection risk and other tradeoffs mean treatment must be individualized within a treat-to-target plan tailored to your disease severity, response history, and risk profile. Because IBD flare patterns overlap with other GI conditions (and because catching worsening disease early dramatically changes outcomes), it's worth clarifying what your current symptoms actually suggest before your next GI visit. A free, instant, online <a href="https://ubiehealth.com/symptom-checker">symptom check</a> can help you organize your symptoms, surface possible causes, and prepare informed questions for your gastroenterologist—so you leave your appointment with a clearer plan, not more uncertainty. Reviewed for medical accuracy: 07/02/2026